Table 2 Prevalence of mold and non-mold sensitization in asthma patients. "Sensitization score" refers to number and size of positive skin tests as defined in methods section.
Asthma No admissions | Asthma One Admission | Asthma >1 admissions | Chi squared p value | |
|---|---|---|---|---|
Mold allergens | ||||
Aspergillus | 7% | 6% | 37% | <0.0001 |
Alternaria | 5% | 6% | 26% | <0.0001 |
Cladosporium | 1% | 0% | 41% | <0.0001 |
Penicillium | 2% | 4% | 30% | <0.0001 |
Candida | 10% | 9% | 33% | 0.001 |
Any mold sensitization | 16% | 19% | 76% | <0.0001 |
>1 mold sensitisation | 5% | 6% | 50% | <0.0001 |
Mean mold sensitization score (95% CI) | 0.9 mm 0.4–1.4 | 0.9 mm 0.3–1.5 | 6.7 mm 4.8–8.5 | Mann Whitney See below |
Other allergens | ||||
D pteronyssinus | 56% | 47% | 67% | 0.13 |
Grass pollen | 46% | 38% | 63% | 0.025 |
Cat | 37% | 36% | 59% | 0.029 |
Dog | 18% | 19% | 48% | 0.005 |
Any non-mold Sensitisation | 70% | 47% | 74% | 0.008 |
>1 non-mold sensitisation | 43% | 38% | 70% | 0.002 |
Mean non-mold sensitization score (95% CI) | 8.6 mm 6.6–10.6 | 7.0 mm 4.7–9.3 | 14.5 mm 11.1–17.9 | Mann Whitney See below |